MDS Virtual Congress 2021 » Parkinson's Disease: Pathophysiology

Meeting: MDS Virtual Congress 2021

Cerebrospinal fluid levels of oxidative stress measured using diacron-reactive oxygen metabolites and biological antioxidant potential in patients with Parkinson’s disease and progressive supranuclear palsy

K. Takahashi, K. Iwaoka, K. Takahashi, Y. Suzuki, K. Taguchi, K. Yamahara, T. Maeda (Yahaba, Shiwa, Iwate, Japan)

Comparative score on the MDS-UPDRS scale I, II and IV in patients with Parkinson disease with and without cardiovascular risk factors.

H. Gonzalez-Usigli, A. Gonzalez-Vazquez, J. Garcia-Rivera, O. Padila-Delatorre, A. Leon-Gil, H. Gonzalez-Rodriguez (Guadalajara, Mexico)

Daily fluctuations of plasma ghrelin level in patients with different motor subtypes of Parkinson`s disease

K. Tarianyk, A. Shkodina (Poltava, Ukraine)

Decreased mesencephalic locomotor region activation explains loss of presynaptic inhibition during step initiation in people with Parkinson´s disease with freezing of gait

J. Lira, C. Ugrinowitsch, M. Nucci, D. Coelho, E. Barbosa, L. Teixeira, E. Júnior, F. Horak, M. Mancini, C. Batista (São Paulo, Brazil)

Do Parkinson’s disease medications have an effect on gut microbiome? A case-control study

P. Zhang, P. Huang, Y. Qian, X. Yang, Y. He, J. Du, G. Li, S. Cui, S. Xu, J. Liu, Y. Lin, Y. Fu, G. He, Z. Zhang, Q. Xiao, S. Chen (Shanghai, China)

Does the observation of an action inserted in an emotion-enriched context influence cortical excitability in patients with Parkinson’s disease?

G. Lagravinese, E. Pelosin, A. Bisio, G. Bonassi, M. Putzolu, A. Botta, C. Cosentino, C. Ponte, S. Mezzarobba, L. Avanzino (Genoa, Italy)

Effects of Angiotensin Type 1 Receptor Antagonists on Parkinson’s Disease Progression: an exploratory study in the PPMI database

L. Udovin, M. Otero-Losada, S. Bordet, G. Chevalier, C. Quarracino, F. Capani, S. Perez-Lloret (Buenos Aires, Argentina)

Effects of levodopa dose on temporal dynamics of cortical activity and postural control in people with Parkinson’s disease

FAB. Barbieri, FAS. Araújo-Silva, FBS. Santinelli, LFI. Imaizumi, APS. Silveira, LHV. Palucci Vieira, LA. Alcock (Bauru, Brazil)

Evaluation of Acoustic Features of Speech for Monitoring Parkinson’s Disease Progression

M. Magee, J. Tamplin, M. Morris, C. Marigliani, F. Baker, A. Tsanas, G. Noffs, A. Vogel (Parkville, Australia)

Evidence of gut dysbiosis in treatment-naïve de novo Parkinson’s disease

J. Boertien, K. Murtomäki, P. Pereira, S. Vander Zee, A. Slomp, T. Mertsalmi, R. Levo, T. Nojonen, P. Laine, L. Paulin, P. Auvinen, V. Kaasinen, F. Scheperjans, T. van Laar (Groningen, Netherlands)

GBA Mutation Accumulates Higher Alpha-Synuclein in Alpha-Synucleinopathies

T. Eid (London, United Kingdom)

Gut microbiota in patients with Parkinson’s disease (PD) predicts disease progression better than clinical features

H. Nishiwaki, M. Ito, T. Hamaguchi, T. Maeda, K. Kashihara, Y. Tsuboi, M. Masahisa, M. Hirayama, K. Ohno (Nagoya City, Japan)

Gut, nasal and oral dysbiosis in Parkinson’s disease

S. Jo, W. Kang, YS. Hwang, SH. Lee, SJ. Chung (Seoul, Republic of Korea)

HbA1c correlates with motor and cognitive outcome scores in patients with Parkinson’s disease and type 2 diabetes.

B. Huxford, T. Haque, A. Joseph, C. Simonet, D. Gallagher, C. Budu, R. Dobson, A. Noyce (London, United Kingdom)

MICROBIAL TRANSLOCATION IN PATIENTS WITH PARKINSON DISEASE AT THE UNIVERSITY TEACHING HOSPITAL, LUSAKA, ZAMBIA: A CASE CONTROL STUDY

L. Chishimba, E. Sinkala, P. Kelly, M. Atadzhanov (Lusaka, Zambia)

Motor Function Test Protocol for Parkinsonian Triad in Rodent Model of Parkinson’s Disease

M. Sirajo, K. Murtala, J. Oyem, O. Ishola, O. Lukman (Kano, Nigeria)

Peripheral immune profile and neutrophil-to-lymphocyte ratio in Parkinson’s disease

L. Muñoz-Delgado, D. Macías-García, S. Jesús, JF. Martin-Rodríguez, MA. Labrador-Espinosa, MV. Jiménez-Jaraba, A. Adarmes-Gómez, F. Carrillo, P. Mir (Sevilla, Spain)

Piecing Together the Gut Microbiome in Parkinson’s Disease: A Meta-Analysis

TS. Toh, CW. Chong, SY. Lim, AH. Tan (Kuala Lumpur, Malaysia)

Quantification of neck and trunk tilt during standing in Parkinson’s disease

H. Matsumoto, M. Shiraishi, H. Mizukami, S. Hino, M. Kaburagi, J. Ono, R. Nakagawa, K. Warashina, S. Mizuno, S. Tochimoto, Y. Yamano (Kawasaki, Japan)

Quantitative 3D movement analysis detects motor improvement earlier than MDS-UPDRS in a levodopa challenge test

R. Barbosa, M. Medonça, R. Oliveira, M. Santos, A. Abreu, P. Bastos, P. Pita-Lobo, A. Valadas, L. Correia-Guedes, J. Ferreirajos, M. Rosa, R. Matias, M. Coelho (Lisbon, Portugal)